Highly accomplished analytical problem-solver focused on supporting and enhancing operations with servant leadership style and strategic approach to decision-making. Extremely knowledgeable about health care industry business practices.
Overview
27
27
years of professional experience
Work History
Associate Director, Sales Analytics & Contracting
Ansell Healthcare Products
Iselin, NJ
04.2019 - Current
Drive the customer allocation processes for exam & surgical gloves to ensure continuity of supply to strategic accounts.
Negotiate and implement acute care GPO/IDN contracts to provide market access for sales teams.
Led a team of managers responsible for providing analytical support to commercial leadership to highlight trends, identify actionable insights, support offer development, and enhance decision making.
Financial Advisor
Edward Jones
Houston, TX
03.2018 - 04.2019
Partner with individuals, families and businesses throughout the community to define financial goals, then develop and monitor customized plans to ensure that clients remain on track to achieve them.
Successfully earned Series 7, Series 66, and Texas life insurance licenses, and LTC/annuity certifications.
Vice President of Finance & National Accounts
TRX Biosurgery
Houston, TX
01.2015 - 03.2018
Provided commercial analytical leadership to drive execution of sales strategy focused on inpatient surgical use of DermaPure, a novel dermal allograft product.
Led National Accounts team in securing multiple GPO new technology contracts, providing improved access to 75% of targeted acute care accounts.
Director of National Accounts
BSN Medical Inc.
Houston, TX
04.2014 - 01.2015
Optimized revenue in $7 million portfolio of GPO/IDN accounts by navigating to key decision makers, articulating value proposition, securing contracts, and coaching field sales to harvest the opportunity.
Secured a major GPO new technology agreement for a key product and partnered to drive 15% growth across Advanced Wound Care portfolio.
Regional Vice President of Managed Care
Byram Healthcare
Houston, TX
07.2013 - 04.2014
Integrated with key executives and other stakeholders within regional managed care accounts to align opportunities and customer goals with the company’s business objectives.
Partnered to drive $1 million of revenue growth in first six months, a 13% year-over-year increase.
National Accounts Director
Acelity
San Antonio, TX
09.2010 - 07.2013
Developed and executed plans to drive $70M of revenue across a portfolio of national managed care organizations.
Sold $2 million of capital equipment to a capital-constrained post-acute market in 2011, implementing an ongoing asset management program to drive deeper customer partnerships and capital repurchases.
Senior Finance Director
Acelity
San Antonio, TX
04.2008 - 09.2010
Directed team of 30 analysts/managers across business operations, decision support, new product analysis, sales forecasting, P&L management and sales reporting for US business unit ($1B in annual revenue).
Achieved $30M reduction in operating expenses to successfully deliver budgeted contribution margin % despite $55M revenue shortfall vs. business plan.
Senior Finance Manager
ArthroCare
Austin, TX
04.2007 - 04.2008
Led Hyperion-based global financial planning process and analysis team supporting CEO, CFO, and senior leadership.
Provided financial management reporting including quarterly reviews, pro forma P&Ls, and Board of Directors executive summaries.
Interim Chief Financial Officer
LivaNova
Houston, TX
11.2006 - 04.2007
In the wake of CEO/CFO resignations and stock option investigation, led organization to achieve SEC filing compliance by submitting a restated 10-K, and two 10-Q filings in less than 3 months.
Negotiated with independent auditors, internal management and the Board of Directors to ensure alignment on $18M restatement of earnings to NASDAQ.
Director, Financial Planning & Analysis
LivaNova
Houston, TX
11.2005 - 11.2006
Developed and implemented COGNOS global planning application, allowing direct business owner input and real-time consolidation of pro forma financial statements.
Performed business unit contribution margin analyses, highlighting cost of driving Treatment Resistant Depression revenue, resulting in a 40% investment re-allocation towards base business Epilepsy franchise.
Finance Management Development Program
Johnson & Johnson
New Brunswick, NJ
05.1997 - 11.2005
Partnered to drive strategic planning process, spanning 30 indications worth sales of over $5 billion, including sales forecasting, portfolio assessment, and preparation of investment risk-adjusted NPV analyses.
Performed valuation analyses related to major business structure negotiation with Schering-Plough, international commercial partner for REMICADE, with deal elements in excess of $1B.
Provided contract development and pricing strategy consultation to Northeast region, covering 28 targeted health systems comprising $385 million in revenue across medical device and pharmaceutical products.
Certified Lean Six Sigma Green Belt - led two contracting process improvement projects contributing $200,000 in annual expense savings.